Why not have Definitive Trials of Gastrointestinal Safety for Non-Steroidal Anti-Inflammatory Drugs? Discussion Paper

Anonymous. CSM Update: Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions - 2. Br Med J 1986; 292: 1190–1

Kurata J. , Elashoff J. , Grossman M.I. Inadequacy of the Literature on the relation-ship between drugs, ulcers and gastrointestinal bleeding. Gastroenterology 1982; 82: 373–82

Elashoff J.D. , Grossman M.I. Trends in hospital admissions and death rates for peptic ulcer in the United States from 1970 to 1978. Gastroenterology 1980; 78: 280–5

Langman M.J.S. The epidemiology of chronic digestive disease. London: Edward-Arnold, 1979: 1–39

Clinch D. Peptic ulcer and its drug causation: The role of non-steroidal anti-inflammatory drugs. London: Croom Helm, 1986: 84–121

Freeborn S. , Clinch D. NSAIDs in the elderly. Pharmaceutical Journal 1985; 234: 464

Allan L. , Dykes P. A study of the factors influencing mortality rates from gastro-intestinal haemorrhage. Q J Med 1976; 180: 533–50

Cohen H.M. Treatment and mortality of perforated ulcers: A survey of 852 cases. Can Med Assoc J 1971; 105: 263–82

Lanza F. , Nelson R.S. , Chen T.T. , Seckman C.E. , Ralk R.N. The effects of ibuprofen, indomethacin, aspirin, naproxen and placebo on the gastric mucosa of normal volunteers. Dig Dis Sci 1971; 24: 823–7

Lanza F. , Umbenhauer R. , Ralk M. , Daurio C. , White L. A double blind randomised placebo controlled gastroscopic study to compare the effects of indomethacin suppositories on the gastric mucosa of human volunteers. J Rheumatol 1982; 9: 415–9

Vakil B.J. , Shah P.N. , Dalal N. , Wagholikar V.N. , Pispati P.K. Endoscopic study of Gastrointestinal injury with non-steroidal anti-inflammatory Drugs. Curr Med Res Opin 1977; 5: 38–42

Pemberton R. , Strand J. A review of upper gastrointestinal effects of the newer. Non-steroidal anti-inflammatory agents. Dig Dis Sci 1982; 24: 53–64

Stephens F.O. , Lawrenson K.B. 51-Cr excretion in bile. Lancet 1969; i: 158–9

Slater F.F. , Delaney V.B. Liver adenosine triphosphate content and bile flow in the rat. Biochem J 1970; 116: 303–8

Inman W.H. Monitoring for drug safety. Lancaster: MTP Press, 1980: 7–48

Snell E.S. Prescription event monitoring. In: Walker S. , Goldberg A. eds. Monitoring for adverse drug reactions. Lancaster: MTP Press, 1984: 59–62

Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. N Engl J Med 1974; 290: 1158–62

Trewby P.N. Drug-induced peptic ulcer and upper gastrointestinal bleeding. Br J Hosp Med 1980; 23: 185–7

Somerville K. , Faulkner G. , Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; i 426–4

Clinch D. , Banerjee A.K. , Levy D.W. , Ostick D.G. Non-steroidal anti-inflammatory drugs and peptic ulcer. J R Coll Physicians Land 1987; 21: 183–7

Collier DStJ , Pain J.A. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 359–63

Hill A.B. The environment and disease: association or causation. Proc R Soc Med 1965; 58: 295–300

Ferriman A. The Observer (London) 1986 Jan 26: 3

Jilk H. , Vessey M. Case control studies in the evaluation of drug induced illness. Am J Epidemiol 1978; 107: 1–7

Permutt R.P. , Cello A. Duodenal ulcer disease in the hospital elderly. Dig Dis Sci 1982; 24: 53–64

Clinch D. , Banerjee A.K. , Ostick D.G. Absence of abdominal pain in elderly patients with peptic ulcer. Age Ageing 1984; 13: 120–3

Kern F. , Clark G.M. , Lukens J.G. Peptic ulceration occurring during therapy for rheumatoid arthritis. Gastroenterology 1957; 33: 25–33

Bonnevie O. The incidence of gastric ulcer in Copenhagen County. Scand J Gastroenterol 1975; 10: 231–9